Ken Griffin’s Abivax ABVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$130M Sell
1,308,467
-129,885
-9% -$15.7M 0.01% 825
2026
Q2
$192M Buy
1,438,352
+894,014
+164% +$101M 0.02% 578
2026
Q1
$60.6M Sell
544,338
-19,409
-3% -$2.3M 0.01% 1182
2025
Q4
$76M Sell
563,747
-118,038
-17% -$12.9M 0.01% 1058
2025
Q3
$57.9M Sell
681,785
-570,472
-46% -$35M 0.01% 1244
2025
Q2
$9.6M Sell
1,252,257
-121,603
-9% -$793K ﹤0.01% 3087
2025
Q1
$8.59M Buy
1,373,860
+518,184
+61% +$3.51M ﹤0.01% 3060
2024
Q4
$6.26M Buy
855,676
+389,247
+83% +$3.58M ﹤0.01% 3612
2024
Q3
$5.37M Buy
466,429
+11,669
+3% +$140K ﹤0.01% 3830
2024
Q2
$6.01M Sell
454,760
-96,750
-18% -$1.38M ﹤0.01% 3462
2024
Q1
$7.89M Sell
551,510
-181,357
-25% -$2.34M ﹤0.01% 3267
2023
Q4
$7.84M Buy
+732,867
New +$7.47M ﹤0.01% 3163

Other funds holding ABVX

Ken Griffin's ABVX Position: Q3 2026 in Review

Ken Griffin reduced its Abivax (ABVX) stake by 9% in Q3 2026, selling an estimated $15.7M and leaving 1,308,467 shares worth $130M. The position accounts for 0.01% of the portfolio, ranked #825.

Ken Griffin first reported a position in ABVX in Q4 2023 and has held it in 12 quarters since. The position peaked at $192M in Q2 2026. 319 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.

  • Ken Griffin held 1,308,467 shares of Abivax worth $130M as of Q3 2026.
  • Ken Griffin sold 129,885 Abivax shares in Q3 2026, an estimated $15.7M.
  • Abivax made up 0.01% of Ken Griffin's portfolio in Q3 2026, its #825 holding.
  • Ken Griffin first reported a position in Abivax in Q4 2023 and has held it in 12 quarters since.
  • Ken Griffin's Abivax position peaked at $192M in Q2 2026.
  • 319 funds tracked by Wall St. Rank held Abivax as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.